NeurologyLive® Friday 5 — October 7, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 7, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Institutional Perspectives in Neurology, Chaired by Riley Bove, MD

Chaired by Riley Bove, MD, of the University of California, San Francisco (UCSF), the presentations—focused on caring for women with MS across the spectrum—also feature Emmanuelle Waubant, MD, PhD, of UCSF; William L. Conte, MD, MS, of Methodist Hospitals; and Maria K. Houtchens, MD, of Harvard Medical School.

Institutional Perspectives in Neurology, Chaired by Riley Bove, MD

2: SRNA Roundtable Discussion: Diagnosis, Presentation, and Treatment Decision Differences Among Rare Neuroimmune Disorders

To learn more about the presentation, diagnosis, and management of these disorders, including how they differ from each other, NeurologyLive® partnered with the Siegal Rare Neuroimmune Association (SRNA) for this educational video series, including Brenda Banwell, MD; Sean Pittock, MD; and Michael Levy, MD, PhD.

SRNA Roundtable Discussion: Diagnosis, Presentation, and Treatment Decision Differences Among Rare Neuroimmune Disorders

3: NeuroVoices: Joe Kardine, MS, OTR, CBIS, on the Functionality and Applicability of the NuroSleeve Powered Arm Brace

In the latest edition of our in-depth Q&A series, the clinical program manager at the Jefferson Center for Neurorestoration discussed a new approach to restoring arm function using a powered arm brace and muscle stimulation system.

NeuroVoices: Joe Kardine, MS, OTR, CBIS, on the Functionality and Applicability of the NuroSleeve Powered Arm Brace

4: An Inside Look at the 2022 RNDS Hybrid Conference

The RNDS, created to bring together those with rare neuroimmune disorders and clinical community together, is a 3-day hybrid educational event held October 7-9 in Los Angeles, California.

An Inside Look at the 2022 RNDS, SRNA's Hybrid Conference

5: FDA Action Update, September 2022: Holds Lifted, Applications, and Approvals

The FDA took a handful of actions in September 2022, including a new approval for amyotrophic lateral sclerosis (ALS), an application acceptance in Huntington disease (HD), and some others. Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

FDA Action Update, September 2022: Holds Lifted, Applications, and Approvals

—————————————————

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.